Latest Articles
08. 04. 2021
Correction of the List of reimbursed medicinal products valid as of 8.4.2021
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
31. 03. 2021
List of reimbursed medicinal products valid as of 1.4.2021
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
26. 03. 2021
COVID-19 Vaccination in Non-covid Clinical Trials
With regard to frequent questions associated also with the extended guideline of MHRA (The Medicines and Healthcare Products Regulatory Agency), the British drug agency,...
15. 03. 2021
Notification of the commencement of distribution activities within the territory of the Czech Republic based upon distribution authorization for medicinal products issued by another EU member state - after Brexit
State Institute for Drug Control hereby informs UK WDL holders providing distribution activities within the territory of the Czech Republic upon distribution authorization...
26. 02. 2021
List of reimbursed medicinal products valid as of 1.3.2021
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
29. 01. 2021
List of reimbursed medicinal products valid as of 1.2.2021
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
cz
